4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-032317
President sold 50,000 shares at an average $70.20 ($3,510,020)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2020-05-22 | Sale | −13,384 | $70.01 | $937,014 | 784,623 | D: show line 1 in the form |
| Novak Rodger President | 2020-05-26 | Sale | −36,616 | $70.27 | $2,573,006 | 748,007 | D: show line 2 in the form |
| Open-market sales · 50,000 sh · avg $70.20 · $3,510,020 | |||||||
Loading xslF345X03/doc4.xml…